Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


20.03.2017

1 Exp Brain Res
1 Exp Neurol
2 Int J Neurosci
1 J Neural Transm (Vienna)
2 J Neurochem
1 Nat Rev Neurosci
5 Nervenarzt
1 Neurochem Res
2 Neurology
1 Neuropsychology
1 Neurosci Lett
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Exp Brain Res

  1. EL MASSRI N, Lemgruber AP, Rowe IJ, Moro C, et al
    Photobiomodulation-induced changes in a monkey model of Parkinson's disease: changes in tyrosine hydroxylase cells and GDNF expression in the striatum.
    Exp Brain Res. 2017 Mar 15. doi: 10.1007/s00221-017-4937.
    PubMed     Text format     Abstract available


    Exp Neurol

  2. BIMPISIDIS Z, M Oberg C, Maslava N, Cenci MA, et al
    Differential effects of gaseous versus injectable anesthetics on changes in regional cerebral blood flow and metabolism induced by l-DOPA in a rat model of Parkinson's disease.
    Exp Neurol. 2017 Mar 8. pii: S0014-4886(17)30066.
    PubMed     Text format     Abstract available


    Int J Neurosci

  3. HE X, Zhang Y, Chen J, Xie C, et al
    The Patterns of EEG Changes in early-onset Parkinson's disease patients.
    Int J Neurosci. 2017 Mar 10:1-26. doi: 10.1080/00207454.2017.1304393.
    PubMed     Text format     Abstract available

  4. JIA F, Hao H, Meng F, Guo Y, et al
    Patient perspectives on the efficacy of a new kind of rechargeable deep brain stimulators(1).
    Int J Neurosci. 2016;126:996-1001.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  5. MULLER T, Riederer P, Grunblatt E
    Simultaneous determination of MAO-A and -B activity following first time intake of an irreversible MAO-B inhibitor in patients with Parkinson's disease.
    J Neural Transm (Vienna). 2017 Mar 15. doi: 10.1007/s00702-017-1705.
    PubMed     Text format     Abstract available


    J Neurochem

  6. BECKER G, Mohamed Ali B, Michel A, Hustadt F, et al
    Comparative assessment of 6-[18 F]fluoro-L-m-tyrosine and 6-[18 F]fluoro-L-dopa to evaluate dopaminergic presynaptic integrity in a Parkinson's disease rat model.
    J Neurochem. 2017 Mar 10. doi: 10.1111/jnc.14016.
    PubMed     Text format     Abstract available

  7. CRUCES-SANDE A, Mendez-Alvarez E, Soto-Otero R
    Copper increases the ability of 6-hydroxydopamine to generate oxidative stress and the ability of ascorbate and glutathione to potentiate this effect: potential implications in Parkinson's disease.
    J Neurochem. 2017 Mar 14. doi: 10.1111/jnc.14019.
    PubMed     Text format     Abstract available


    Nat Rev Neurosci

  8. PRZEDBORSKI S
    The two-century journey of Parkinson disease research.
    Nat Rev Neurosci. 2017;18:251-259.
    PubMed     Text format     Abstract available


    Nervenarzt

  9. BROCKMANN K, Berg D
    [New therapy approaches for Parkinson's disease].
    Nervenarzt. 2017 Mar 13. doi: 10.1007/s00115-017-0299.
    PubMed     Text format     Abstract available

  10. BERG D
    [Parkinson - 200 years after first description of the shaking palsy].
    Nervenarzt. 2017 Mar 13. doi: 10.1007/s00115-017-0303.
    PubMed     Text format    

  11. JOST WH
    [Pharmacological treatment of motor symptoms in Parkinson's diseases].
    Nervenarzt. 2017 Mar 13. doi: 10.1007/s00115-017-0309.
    PubMed     Text format     Abstract available

  12. LILL CM, Klein C
    [Epidemiology and causes of Parkinson's disease].
    Nervenarzt. 2017 Mar 13. doi: 10.1007/s00115-017-0288.
    PubMed     Text format     Abstract available

  13. WALTER U, Zach H, Liepelt-Scarfone I, Maetzler W, et al
    [Helpful instrumental examinations in idiopathic Parkinson's disease].
    Nervenarzt. 2017 Mar 13. doi: 10.1007/s00115-017-0289.
    PubMed     Text format     Abstract available


    Neurochem Res

  14. HAINING RL, Jones TM, Hernandez A
    Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy.
    Neurochem Res. 2016;41:3356-3363.
    PubMed     Text format     Abstract available


    Neurology

  15. NONNEKES J, Janssen S, Bloem BR
    Superficial brain stimulation to overcome freezing of gait in Parkinson disease.
    Neurology. 2017 Mar 15. pii: 10.1212/WNL.0000000000003859.
    PubMed     Text format    

  16. SAARI L, Kivinen K, Gardberg M, Joutsa J, et al
    Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease.
    Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003810.
    PubMed     Text format     Abstract available


    Neuropsychology

  17. DISSANAYAKA NN, Au TR, Angwin AJ, O'Sullivan JD, et al
    N400 and Emotional Word Processing in Parkinson's Disease.
    Neuropsychology. 2017 Mar 13. doi: 10.1037/neu0000333.
    PubMed     Text format     Abstract available


    Neurosci Lett

  18. WANG L, Huang J, Pang S, Qin X, et al
    Genetic analysis of the ATG16L1 gene promoter in sporadic Parkinson's disease.
    Neurosci Lett. 2017;646:30-35.
    PubMed     Text format     Abstract available


    PLoS One

  19. FUJIWARA M, Ding C, Kaunitz L, Stout JC, et al
    Optokinetic nystagmus reflects perceptual directions in the onset binocular rivalry in Parkinson's disease.
    PLoS One. 2017;12:e0173707.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  20. MOLLENHAUER B, Weintraub D
    The depressed brain in Parkinson's disease: Implications for an inflammatory biomarker.
    Proc Natl Acad Sci U S A. 2017 Mar 10. pii: 201700737.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: